BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9760168)

  • 1. Interferon-gamma variants with deletions in the AB surface loop--flexibility is a critical point for receptor binding.
    Waschütza G; Dengler U; Villmann C; Böttinger H; Otto B
    Eur J Biochem; 1998 Sep; 256(2):303-9. PubMed ID: 9760168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered disulfide bonds in recombinant human interferon-gamma: the impact of the N-terminal helix A and the AB-loop on protein stability.
    Waschütza G; Li V; Schäfer T; Schomburg D; Villmann C; Zakaria H; Otto B
    Protein Eng; 1996 Oct; 9(10):905-12. PubMed ID: 8931130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, characterization, and structure of a biologically active single-chain mutant of human IFN-gamma.
    Landar A; Curry B; Parker MH; DiGiacomo R; Indelicato SR; Nagabhushan TL; Rizzi G; Walter MR
    J Mol Biol; 2000 May; 299(1):169-79. PubMed ID: 10860730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The structure and activity of a monomeric interferon-gamma:alpha-chain receptor signaling complex.
    Randal M; Kossiakoff AA
    Structure; 2001 Feb; 9(2):155-63. PubMed ID: 11250200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A point mutation that decreases the thermal stability of human interferon gamma.
    Lunn CA; Fossetta J; Murgolo N; Zavodny PJ; Lundell D; Narula SK
    Protein Eng; 1992 Apr; 5(3):249-52. PubMed ID: 1409545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear translocation of IFN-gamma is an intrinsic requirement for its biologic activity and can be driven by a heterologous nuclear localization sequence.
    Subramaniam PS; Green MM; Larkin J; Torres BA; Johnson HM
    J Interferon Cytokine Res; 2001 Nov; 21(11):951-9. PubMed ID: 11747627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carboxy-terminal truncated rhuIFN-gamma with a substitution of Gln133 or Ser132 to leucine leads to higher biological activity than in the wild type.
    Slodowski O; Böhm J; Schöne B; Otto B
    Eur J Biochem; 1991 Dec; 202(3):1133-40. PubMed ID: 1662603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observation of an unexpected third receptor molecule in the crystal structure of human interferon-gamma receptor complex.
    Thiel DJ; le Du MH; Walter RL; D'Arcy A; Chène C; Fountoulakis M; Garotta G; Winkler FK; Ealick SE
    Structure; 2000 Sep; 8(9):927-36. PubMed ID: 10986460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A point mutation of human interferon gamma abolishes receptor recognition.
    Lunn CA; Fossetta J; Dalgarno D; Murgolo N; Windsor W; Zavodny PJ; Narula SK; Lundell D
    Protein Eng; 1992 Apr; 5(3):253-7. PubMed ID: 1409546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystallization of the complex of human IFN-gamma and the extracellular domain of the IFN-gamma receptor.
    Chène C; Fountoulakis M; Döbeli H; D'Arcy B; Winkler F; D'Arcy A
    Proteins; 1995 Dec; 23(4):591-4. PubMed ID: 8749856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signaling by covalent heterodimers of interferon-gamma. Evidence for one-sided signaling in the active tetrameric receptor complex.
    Krause CD; Lunn CA; Izotova LS; Mirochnitchenko O; Kotenko SV; Lundell DJ; Narula SK; Pestka S
    J Biol Chem; 2000 Jul; 275(30):22995-3004. PubMed ID: 10811814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic mutational mapping of sites on human interferon-beta-1a that are important for receptor binding and functional activity.
    Runkel L; deDios C; Karpusas M; Betzenhauser M; Muldowney C; Zafari M; Benjamin CD; Miller S; Hochman PS; Whitty A
    Biochemistry; 2000 Mar; 39(10):2538-51. PubMed ID: 10704203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a synthetic peptide corresponding to a receptor binding domain of mouse interferon gamma.
    Magazine HI; Johnson HM
    Biochemistry; 1991 Jun; 30(23):5784-9. PubMed ID: 1828370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-induced assembly and activation of the gamma interferon receptor in intact cells.
    Bach EA; Tanner JW; Marsters S; Ashkenazi A; Aguet M; Shaw AS; Schreiber RD
    Mol Cell Biol; 1996 Jun; 16(6):3214-21. PubMed ID: 8649432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The unique C termini of orthopoxvirus gamma interferon binding proteins are essential for ligand binding.
    Nuara AA; Bai H; Chen N; Buller RM; Walter MR
    J Virol; 2006 Nov; 80(21):10675-82. PubMed ID: 16928759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural elements required for receptor recognition of human interferon-gamma.
    Lundell DL; Narula SK
    Pharmacol Ther; 1994 Oct; 64(1):1-21. PubMed ID: 7531344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of truncated human interferon gamma variants with the interferon gamma receptor: crucial importance of Arg-129.
    Haelewyn J; Michiels L; Verhaert P; Hoylaerts MF; Witters R; De Ley M
    Biochem J; 1997 Jun; 324 ( Pt 2)(Pt 2):591-5. PubMed ID: 9182722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of a complex between interferon-gamma and its soluble high-affinity receptor.
    Walter MR; Windsor WT; Nagabhushan TL; Lundell DJ; Lunn CA; Zauodny PJ; Narula SK
    Nature; 1995 Jul; 376(6537):230-5. PubMed ID: 7617032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human IFN-alpha protein engineering: the amino acid residues at positions 86 and 90 are important for antiproliferative activity.
    Hu R; Bekisz J; Schmeisser H; McPhie P; Zoon K
    J Immunol; 2001 Aug; 167(3):1482-9. PubMed ID: 11466368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topology of receptor binding domains of mouse IFN-gamma.
    Jarpe MA; Johnson HM
    J Immunol; 1990 Nov; 145(10):3304-9. PubMed ID: 1700005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.